U.C.L.A. Rheumatology Pathophysiology of Disease Course Lecture, |
||||||||||||||||||||||
Page 14 | ||||||||||||||||||||||
Rheumatoid Arthritis Page 14 |
......Index Go to Previous page .....Go to Next page | |||||||||||||||||||||
|
||||||||||||||||||||||
damage. They are the predominant lymphocyte population in the proliferative synovium and they release cytokines which amplify and perpetuate inflammation in the joints and activate B cells (figure 5). They are believed to be activated through the RA-related MHC Class II epitope described above in combination with a disease-provoking antigenic peptide or with a super-antigen that binds to the MHC. The pathogenic sets of T cells are suspected to share certain common T cell receptors. |
||||||||||||||||||||||
Figure 4. A closeup of the schematic drawing of HLA-DR4 in figure 3. Click thumbnail figure to view full graphic. 219 x 164 pixels 16kbs | ||||||||||||||||||||||
Click Picture or here for larger slide and further discussion (640 x 480) 53kb | ||||||||||||||||||||||
Figure 5. A scheme demonstrating the effects of T cell activation is depicted. Click thumbnail figure to view full graphic.. 219 x 164 pixels 10kbs | ||||||||||||||||||||||
Click Picture or here for larger slide and further discussion (640 x 480) 44kb | ||||||||||||||||||||||
Page 14 | ||||||||||||||||||||||
......Index Go to Previous page .....Go to Next page | ||||||||||||||||||||||
About Us | Contact Us | ©2005 | This web site has been developed and maintained by Craig W. Wiesenhutter, M.D. | |||||||||||||||||||||